These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Benefit-risk assessment of antileukotrienes in the management of asthma. García-Marcos L; Schuster A; Pérez-Yarza EG Drug Saf; 2003; 26(7):483-518. PubMed ID: 12735786 [TBL] [Abstract][Full Text] [Related]
24. The effects of cromolyn sodium and nedocromil sodium in early asthma prevention. König P J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 2):S575-81. PubMed ID: 10669542 [TBL] [Abstract][Full Text] [Related]
25. Drug therapy of childhood asthma. Balachandran A; Shivbalan S; Subramanyam L Indian J Pediatr; 2001 Sep; 68 Suppl 4():S12-6. PubMed ID: 11980463 [TBL] [Abstract][Full Text] [Related]
26. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma. Jarvis B; Faulds D Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302 [TBL] [Abstract][Full Text] [Related]
28. Inhaled nonsteroidal anti-inflammatory medications in the treatment of asthma. Krawiec ME; Wenzel SE Respir Care Clin N Am; 1999 Dec; 5(4):555-74. PubMed ID: 10565881 [TBL] [Abstract][Full Text] [Related]
29. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma. Adkins JC; Brogden RN Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793 [TBL] [Abstract][Full Text] [Related]
30. Review: Pharmacological treatment of airway remodeling: inhaled corticosteroids or antileukotrienes? Riccioni G; Di Ilio C; D'Orazio N Ann Clin Lab Sci; 2004; 34(2):138-42. PubMed ID: 15228224 [TBL] [Abstract][Full Text] [Related]
32. [Indication and effect of inhaled DSCG for the treatment of adult asthmatics]. Arai Y Nihon Rinsho; 1996 Nov; 54(11):3023-8. PubMed ID: 8950948 [TBL] [Abstract][Full Text] [Related]
33. The current place of nedocromil sodium in the treatment of asthma. Pauwels R J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 2):S151-5; discussion S155-6. PubMed ID: 8939191 [TBL] [Abstract][Full Text] [Related]
34. Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists. Riccioni G; Bucciarelli T; Mancini B; Di Ilio E; Palumbo G; D'Orazio N Clin Ter; 2007; 158(4):363-70. PubMed ID: 17953289 [TBL] [Abstract][Full Text] [Related]
35. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma. Dunn CJ; Goa KL Drugs; 2001; 61(2):285-315. PubMed ID: 11270943 [TBL] [Abstract][Full Text] [Related]
36. Nedocromil: a new agent for the treatment of asthma. Keenan JM Am Fam Physician; 1994 Oct; 50(5):1059-64. PubMed ID: 7942403 [TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory therapy for asthma. Barnes PJ Annu Rev Med; 1993; 44():229-42. PubMed ID: 8476245 [TBL] [Abstract][Full Text] [Related]
38. Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma. Brogden RN; Sorkin EM Drugs; 1993 May; 45(5):693-715. PubMed ID: 7686465 [TBL] [Abstract][Full Text] [Related]
39. Newer and alternative non-steroidal treatments for asthmatic inflammation. Dykewicz MS Allergy Asthma Proc; 2001; 22(1):11-5. PubMed ID: 11227911 [TBL] [Abstract][Full Text] [Related]
40. New strategies in the medical management of asthma. Gross KM; Ponte CD Am Fam Physician; 1998 Jul; 58(1):89-100, 109-12. PubMed ID: 9672431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]